Cerebrospinal fluid penetration and pharmacokinetics of vancomycin administered by continuous infusion to mechanically ventilated patients in an intensive care unit.
Cerebrospinal fluid (CSF) penetration and the pharmacokinetics of vancomycin were studied after continuous infusion (50 to 60 mg/kg of body weight/day after a loading dose of 15 mg/kg) in 13 mechanically ventilated patients hospitalized in an intensive care unit. Seven patients were treated for a sensitive bacterial meningitis and the other six patients, who had a severe concomitant neurologic disease with intracranial hypertension, were treated for various infections. Vancomycin CSF penetration was significantly higher (P < 0.05) in the meningitis group (serum/CSF ratio, 48%) than in the other group (serum/CSF ratio, 18%). Vancomycin pharmacokinetic parameters did not differ from those obtained with conventional dosing. No adverse effect was observed, in particular with regard to renal function.
Albanèse
J
J
Intensive Care Unit and Trauma Center, Nord Hospital, Marseilles University Hospital System, Marseilles, France.
Léone
M
M
Bruguerolle
B
B
Ayem
M L
ML
Lacarelle
B
B
Martin
C
C
D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000134:cerebrospinal fluid*; D005260:Female; D006801:Humans; D007362:Intensive Care Units; D008297:Male; D016920:Meningitis, Bacterial / Q000188:drug therapy / Q000378:metabolism*; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D012121:Respiration, Artificial; D014640:Vancomycin / Q000008:administration & dosage / Q000009:adverse effects / Q000134:cerebrospinal fluid*
D000900:Anti-Bacterial Agents; D014640:Vancomycin